Search clinical trials for: MCLA-117 bispecific antibody
Total 237 results
-
Merus N.V.Active, not recruitingAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Italy, Netherlands, Belgium, France
-
Merus N.V.Incyte CorporationRecruitingAdvanced Cancer | Solid Tumor, Adult | B-cell Lymphoma, AdultUnited States, Spain, Belgium, Netherlands
-
Merus N.V.RecruitingNSCLC Harboring NRG1 Fusion | Solid Tumours Harboring NRG1 Fusion | Pancreatic Cancer Harboring NRG1 Fusion | NRG1 FusionSpain, France, Israel, Belgium, Denmark, United States, Korea, Republic of, Japan, Germany, Netherlands, Austria, Canada, Italy, Norway, Singapore, Sweden, Taiwan, United Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Acute Leukemia | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Systemic Mastocytosis | Recurrent Hematologic Malignancy | Hairy Cell Leukemia | Chronic... and other conditions
-
Y-mAbs TherapeuticsTerminatedOsteosarcoma | Neuroblastoma | Other Solid Tumor CancersUnited States
-
Radboud University Medical CenterCompleted
-
Merus N.V.RecruitingGastric Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Non-Small Cell Lung Cancer MetastaticUnited States, Spain, France, Italy, Netherlands, Belgium, Korea, Republic of, Germany, Singapore
-
OncoMed Pharmaceuticals, Inc.CompletedAdvanced Solid Tumor MalignanciesUnited States
-
Nanfang Hospital, Southern Medical UniversityNot yet recruitingAdvanced Solid TumorsChina
-
OncoMed Pharmaceuticals, Inc.TerminatedMetastatic Colorectal CancerUnited States
-
Abramson Cancer Center at Penn MedicineXencor, Inc.Active, not recruiting
-
Xiangya Hospital of Central South UniversityActive, not recruiting
-
LiuYingNot yet recruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Qilu Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)TerminatedLymphoma | LeukemiaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedEsophageal Cancer | Non-Small Cell Lung Cancer | Metastatic Solid TumorsUnited States, Canada
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedHER2 Expressing Solid TumoursUnited States, Germany
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedExtranodal NK/T Cell Lymphoma, Nasal TypeChina
-
Shanghai Zhongshan HospitalRecruitingBiliary Tract Cancer | Candonilimab | Claudin 18.2China
-
Memorial Sloan Kettering Cancer CenterUniversity of VirginiaActive, not recruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Advanced Pancreatic CancerUnited States
-
Tianjin Medical University Cancer Institute and...RecruitingHepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectableChina
-
Bio-Thera SolutionsSun Yat-sen UniversityRecruiting
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruitingAdvanced Solid TumorChina
-
ABL Bio, Inc.Recruiting
-
Beijing Mabworks Biotech Co., Ltd.RecruitingHER2-positive Recurrent or Metastatic Malignant Solid TumorChina
-
Shanghai Henlius BiotechNot yet recruiting
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingLocally Advanced Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Anaplastic Carcinoma | Metastatic Thyroid Gland Oncocytic CarcinomaUnited States
-
Guangzhou Excelmab Inc.RecruitingSafety and Efficacy of EX103 in Subjects With Relapsed/Refractory CD20-Positive Non-Hodgkin LymphomaCD20-positive Non-Hodgkin LymphomaChina
-
Radboud University Medical CenterDutch Cancer SocietyCompletedAdenoid Cystic Carcinoma | Salivary Gland Cancer | Salivary Duct CarcinomaNetherlands
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Colorectal CancerChina
-
Hangzhou Sumgen Biotech Co., Ltd.RecruitingSG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.Lymphoma | Hematological MalignancyUnited States
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Gastric CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast CancerAdvanced Breast CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Liver CancerChina
-
Shanghai Henlius BiotechRecruitingLymphoma | Advanced Tumors | Metastatic TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Malignant Tumors LymphomasUnited States
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Pancreatic CancerChina
-
Nantes University HospitalCompletedThyroid NeoplasmsFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | Adult Acute Lymphoblastic Leukemia in Complete RemissionUnited States
-
GenmabRecruitingSquamous Non Small Cell Lung Cancer (NSCLC-SCC) | Breast Cancer, Breast Neoplasms | Endometrial Cancer, Endometrial Neoplasm | Ovarian Cancer, Ovarian NeoplasmsUnited States, France, Spain, Netherlands, Belgium, United Kingdom, Denmark, Italy, Poland
-
Sheba Medical CenterDan Hauzenberger M.D., Ph.D. Assoc. Professor, Karolinska University Hospital...Not yet recruiting
-
Gilead SciencesCompletedPancreatic CancerUnited States
-
Gilead SciencesCompleted
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney CancerAdvanced Kidney CancerChina
-
Fuda Cancer Hospital, GuangzhouBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.WithdrawnAdvanced Lung CancerChina
-
Stony Brook UniversityCompleted
-
Peking University First HospitalNot yet recruiting
-
PfizerCompletedMultiple MyelomaCanada, United States